Targeting the Bcl-2 Family in B Cell Lymphoma

Overview

Journal Front Oncol

Specialty Oncology

Date 2019 Jan 24

PMID 30671383

Citations 67

Authors

Clare M Adams

Sean Clark-Garvey

Pierluigi Porcu

Christine M Eischen

Affiliations

Soon will be listed here.

Abstract

Although lymphoma is a very heterogeneous group of biologically complex malignancies, tumor cells across all B cell lymphoma subtypes share a set of underlying traits that promote the development and sustain malignant B cells. One of these traits, the ability to evade apoptosis, is essential for lymphoma development. Alterations in the Bcl-2 family of proteins, the key regulators of apoptosis, is a hallmark of B cell lymphoma. Significant efforts have been made over the last 30 years to advance knowledge of the biology, molecular mechanisms, and therapeutic potential of targeting Bcl-2 family members. In this review, we will highlight the complexities of the Bcl-2 family, including our recent discovery of overexpression of the anti-apoptotic Bcl-2 family member Bcl-w in lymphomas, and describe recent advances in the field that include the development of inhibitors of anti-apoptotic Bcl-2 family members for the treatment of B cell lymphomas and their performance in clinical trials.

Citing Articles

BCL-2 inhibitors in hematological malignancies: biomarkers that predict response and management strategies.

Markouli M, Pagoni M, Diamantopoulos P Front Oncol. 2025; 14:1501950.

PMID: 39906657 PMC: 11790632. DOI: 10.3389/fonc.2024.1501950.

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets.

Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y MedComm (2020). 2024; 5(12):e70024.

PMID: 39619229 PMC: 11604731. DOI: 10.1002/mco2.70024.

BCL2i-Based Therapies and Emerging Resistance in Chronic Lymphocytic Leukemia.

Li W, Atalla E, Dong J, Konopleva M Cells. 2024; 13(22).

PMID: 39594670 PMC: 11592612. DOI: 10.3390/cells13221922.

Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia.

Goulart H, Kantarjian H, Pemmaraju N, Daver N, DiNardo C, Rausch C Blood Cancer Discov. 2024; 6(1):23-37.

PMID: 39565177 PMC: 11707511. DOI: 10.1158/2643-3230.BCD-24-0171.

Selenomethionine Inhibited HADV-Induced Apoptosis Mediated by ROS through the JAK-STAT3 Signaling Pathway.

Li C, Liu X, Li J, Lai J, Su J, Zhu B Nutrients. 2024; 16(12).

PMID: 38931321 PMC: 11206631. DOI: 10.3390/nu16121966.

References

Zong W, Edelstein L, Chen C, Bash J, Gelinas C . The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev. 1999; 13(4):382-7. PMC: 316475. DOI: 10.1101/gad.13.4.382. View

Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T . bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J Exp Med. 1999; 189(11):1691-8. PMC: 2193080. DOI: 10.1084/jem.189.11.1691. View

Gross A, McDonnell J, Korsmeyer S . BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999; 13(15):1899-911. DOI: 10.1101/gad.13.15.1899. View

Bairey O, Zimra Y, Shaklai M, Okon E, Rabizadeh E . Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas. Clin Cancer Res. 1999; 5(10):2860-6. View

Kuss A, KNODEL M, Berberich-Siebelt F, Lindemann D, Schimpl A, Berberich I . A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. Eur J Immunol. 1999; 29(10):3077-88. DOI: 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R. View

Bouillet P, Metcalf D, Huang D, Tarlinton D, Kay T, Kontgen F . Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999; 286(5445):1735-8. DOI: 10.1126/science.286.5445.1735. View

Puthier D, Derenne S, Barille S, Moreau P, Harousseau J, Bataille R . Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells. Br J Haematol. 1999; 107(2):392-5. DOI: 10.1046/j.1365-2141.1999.01705.x. View

Breitschopf K, Haendeler J, Malchow P, Zeiher A, Dimmeler S . Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol Cell Biol. 2000; 20(5):1886-96. PMC: 85374. DOI: 10.1128/MCB.20.5.1886-1896.2000. View

Wagner K, Claudio E, Rucker 3rd E, Riedlinger G, Broussard C, Schwartzberg P . Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development. 2000; 127(22):4949-58. DOI: 10.1242/dev.127.22.4949. View

10.

Huang D, Strasser A . BH3-Only proteins-essential initiators of apoptotic cell death. Cell. 2001; 103(6):839-42. DOI: 10.1016/s0092-8674(00)00187-2. View

11.

LINDSTEN T, Ross A, King A, Zong W, Rathmell J, Shiels H . The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2001; 6(6):1389-99. PMC: 3057227. DOI: 10.1016/s1097-2765(00)00136-2. View

12.

Pinton P, Ferrari D, Rapizzi E, Di Virgilio F, Pozzan T, Rizzuto R . The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 2001; 20(11):2690-701. PMC: 125256. DOI: 10.1093/emboj/20.11.2690. View

13.

Zhou P, Levy N, Xie H, Qian L, Lee C, Gascoyne R . MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood. 2001; 97(12):3902-9. DOI: 10.1182/blood.v97.12.3902. View

14.

Zong W, LINDSTEN T, Ross A, Macgregor G, Thompson C . BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 2001; 15(12):1481-6. PMC: 312722. DOI: 10.1101/gad.897601. View

15.

Eischen C, Woo D, Roussel M, Cleveland J . Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol. 2001; 21(15):5063-70. PMC: 87232. DOI: 10.1128/MCB.21.15.5063-5070.2001. View

16.

Eischen C, Roussel M, Korsmeyer S, Cleveland J . Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol. 2001; 21(22):7653-62. PMC: 99936. DOI: 10.1128/MCB.21.22.7653-7662.2001. View

17.

Eischen C, Packham G, Nip J, Fee B, Hiebert S, Zambetti G . Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene. 2001; 20(48):6983-93. DOI: 10.1038/sj.onc.1204892. View

18.

Zhang B, Gojo I, Fenton R . Myeloid cell factor-1 is a critical survival factor for multiple myeloma. Blood. 2002; 99(6):1885-93. DOI: 10.1182/blood.v99.6.1885. View

19.

Agarwal B, Naresh K . Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases. Am J Hematol. 2002; 70(4):278-82. DOI: 10.1002/ajh.10139. View

20.

van de Donk N, Kamphuis M, van Dijk M, Borst H, Bloem A, Lokhorst H . Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein. Leukemia. 2003; 17(1):211-9. DOI: 10.1038/sj.leu.2402768. View